| Product Code: ETC12732970 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Neoantigen Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Neoantigen Market - Industry Life Cycle |
3.4 South Korea Neoantigen Market - Porter's Five Forces |
3.5 South Korea Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 South Korea Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Korea Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in RD for personalized medicine |
4.2.2 Rising prevalence of cancer and demand for innovative treatment options |
4.2.3 Government support for biotechnology and healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neoantigen therapies |
4.3.2 High costs associated with research, development, and production of neoantigen-based treatments |
5 South Korea Neoantigen Market Trends |
6 South Korea Neoantigen Market, By Types |
6.1 South Korea Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 South Korea Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 South Korea Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 South Korea Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Korea Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 South Korea Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 South Korea Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 South Korea Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Korea Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 South Korea Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 South Korea Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 South Korea Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 South Korea Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 South Korea Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 South Korea Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 South Korea Neoantigen Market Import-Export Trade Statistics |
7.1 South Korea Neoantigen Market Export to Major Countries |
7.2 South Korea Neoantigen Market Imports from Major Countries |
8 South Korea Neoantigen Market Key Performance Indicators |
8.1 Number of clinical trials involving neoantigen therapies in South Korea |
8.2 Percentage of healthcare providers offering neoantigen-based treatments |
8.3 Level of collaboration between research institutions and biopharmaceutical companies in developing neoantigen therapies |
9 South Korea Neoantigen Market - Opportunity Assessment |
9.1 South Korea Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 South Korea Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Korea Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Neoantigen Market - Competitive Landscape |
10.1 South Korea Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 South Korea Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here